A gastroscopy can provide valuable information about the oesophagus, stomach and first part of the small intestine, but the findings discussed immediately after the procedure are not always the final diagnosis. The endoscopist can describe what was visible and any treatment performed, while biopsies require microscopic examination by a pathologist.
Biopsies are routinely taken for many reasons and do not necessarily indicate that cancer is suspected. They can identify inflammation, Helicobacter pylori infection, coeliac disease, cellular changes in Barrett’s oesophagus and other conditions that may not be confirmed by visual examination alone.
Understanding the difference between the procedural impression, the pathology report and the final clinical interpretation can reduce unnecessary anxiety while ensuring that important follow-up is not overlooked.
Key points
- Gastroscopy examines the oesophagus, stomach and duodenum using a flexible endoscope.
- The endoscopist may identify visible abnormalities immediately, but biopsies and some final diagnoses require pathology.
- A biopsy is not synonymous with suspected cancer. Tissue may be sampled to investigate infection, inflammation, coeliac disease or microscopic changes.
- Common findings include reflux-related inflammation, gastritis, hiatus hernia, ulcers, polyps and a macroscopically normal upper digestive tract.
- Treatment and follow-up depend on the complete result, symptoms, medicines, medical history and individual risk factors.
Article index
- Understanding the different parts of a gastroscopy result
- What does a normal gastroscopy result mean?
- Common findings during gastroscopy
- Oesophagitis and reflux-related changes
- Barrett’s oesophagus
- Hiatus hernia
- Gastritis and Helicobacter pylori
- Stomach and duodenal ulcers
- Coeliac disease and duodenal biopsies
- Gastric polyps and other lesions
- Why are biopsies taken?
- Understanding the pathology report
- How long do biopsy results take?
- What happens after the results?
- Questions to ask about your gastroscopy result
- When should you seek medical advice?
- How Direct Endoscopy can help
- Final thoughts
1. Understanding the different parts of a gastroscopy result
The term “gastroscopy result” can refer to several related documents and clinical assessments. The first is the endoscopist’s immediate visual impression. A thin, flexible endoscope is passed through the mouth to examine the oesophagus, stomach and duodenum. The camera displays the mucosal surface on a monitor, allowing the specialist to identify visible inflammation, ulcers, narrowing, bleeding, polyps or other lesions.
The second component is the formal procedure report. It commonly records the indication for the examination, the areas reached, relevant findings, photographs, biopsies and any treatment performed. It may also describe whether the procedure was complete and whether technical limitations affected examination quality.
The third component is histopathology. A pathologist examines tissue samples microscopically and may use special stains or additional tests. This analysis can confirm the nature of inflammation, identify infection, assess abnormal cellular changes or determine whether a lesion is benign, precancerous or malignant.
The final interpretation integrates the visual findings, pathology, symptoms, medicines, blood tests, imaging and relevant medical history. An isolated phrase in a procedure report should not be used to self-diagnose or predict treatment.
Sedation can temporarily affect memory. Patients should retain written information and attend the recommended review rather than relying solely on the brief discussion after waking.
2. What does a normal gastroscopy result mean?
A macroscopically normal gastroscopy means the endoscopist did not identify a significant visible abnormality in the adequately examined upper gastrointestinal tract. This can be reassuring, but it does not always explain the symptoms that prompted investigation.
Some conditions are microscopic. Coeliac disease, subtle inflammation and particular cellular changes may require biopsies even when the surface appears normal. A visually normal examination can therefore still be followed by an abnormal pathology result.
Symptoms such as reflux, nausea, upper abdominal discomfort or functional dyspepsia may also occur without structural abnormalities visible on gastroscopy. Disorders of motility, visceral sensitivity and conditions outside the upper gastrointestinal tract are not excluded solely by a normal endoscopy.
The significance of a normal result depends on the clinical question and whether the examination was complete. If symptoms persist, worsen or change, follow the advice of the GP or specialist. New difficulty swallowing, gastrointestinal bleeding, persistent vomiting, unintended weight loss or unexplained anaemia requires medical review.
3. Common findings during gastroscopy
Many findings are benign or treatable. Their importance varies according to severity, distribution, pathology and the patient’s broader clinical circumstances. Commonly documented findings include:
- oesophagitis or irritation of the oesophageal lining
- changes associated with gastro-oesophageal reflux
- Barrett’s oesophagus
- hiatus hernia
- gastritis
- gastric or duodenal ulcers
- duodenitis
- gastric polyps
- narrowing or strictures
- vascular abnormalities or a source of bleeding
- a suspicious mass or lesion
Visual terminology describes appearance, not necessarily cause. For example, “erythema” means redness and can occur for several reasons. “Erosion” describes superficial mucosal damage, while an ulcer is a deeper defect. Biopsy and clinical correlation may be needed before treatment is determined.
4. Oesophagitis and reflux-related changes
Oesophagitis is inflammation or injury affecting the oesophageal lining. Gastro-oesophageal reflux disease is a common cause, occurring when stomach contents repeatedly move upwards into the oesophagus.
Gastroscopy may show redness, breaks in the mucosa, ulceration, narrowing or other reflux-associated changes. The severity and distribution can help guide management, but symptom severity does not always correspond precisely with visible damage. Some people have troublesome reflux with little visible inflammation, while others have oesophagitis with relatively modest symptoms.
Other causes of oesophagitis include medicines, infection, allergic or immune-mediated disorders and injury. Eosinophilic oesophagitis, for example, requires oesophageal biopsies because characteristic microscopic findings are central to diagnosis.
Treatment depends on cause and can involve acid suppression, medication review, dietary management, treatment of infection or specialist follow-up. A narrowing may require additional evaluation or endoscopic dilatation.
5. Barrett’s oesophagus
Barrett’s oesophagus is a change in the lining of the lower oesophagus associated with chronic reflux exposure. The usual squamous lining is replaced by a different type of epithelium. Diagnosis depends on endoscopic assessment together with pathology.
Barrett’s oesophagus is not cancer. It is clinically important because it is associated with an increased risk of oesophageal adenocarcinoma, although most people with Barrett’s oesophagus do not develop cancer.
Biopsies are taken to confirm the diagnosis and assess for dysplasia. Dysplasia refers to abnormal cellular development and may be reported as absent, indefinite, low grade or high grade. Interpretation can be complex, and significant dysplasia may require review by an expert gastrointestinal pathologist.
Management can include reflux treatment, surveillance gastroscopy and, when clinically indicated, endoscopic therapy. The interval is individualised according to the length of the Barrett’s segment, pathology and other risk factors.
6. Hiatus hernia
A hiatus hernia occurs when part of the stomach moves upwards through the opening in the diaphragm through which the oesophagus passes. It is common and may be discovered incidentally.
A hiatus hernia can contribute to reflux by altering the normal barrier between the oesophagus and stomach, but not every person with a hernia has symptoms. Its presence does not automatically establish the cause of all upper abdominal or chest symptoms.
Small sliding hiatus hernias are often managed conservatively when treatment is needed. Management may focus on reflux control and relevant lifestyle measures. Larger or complicated hernias may require additional imaging, specialist assessment or surgery.
Biopsy does not diagnose the hernia itself. Tissue may nevertheless be sampled if inflammation, Barrett’s change or another mucosal abnormality is present.
7. Gastritis and Helicobacter pylori
Gastritis means inflammation of the stomach lining. The term can describe a visual impression, a microscopic diagnosis or both. Redness seen during gastroscopy does not always correspond with the severity or cause of histological inflammation.
Helicobacter pylori is a bacterium that can colonise the stomach and cause chronic gastritis. It is associated with peptic ulcer disease and an increased long-term risk of particular gastric cancers. The infection can be assessed using gastric biopsies, a breath test or a stool antigen test, depending on the clinical context.
Other causes of gastritis or gastric injury include anti-inflammatory medicines, autoimmune disease, bile reflux, alcohol and less common infections. Treatment depends on the underlying process rather than the word “gastritis” alone.
If H. pylori is identified, eradication treatment generally uses a combination of acid-suppressing and antimicrobial medicines. Confirmation that treatment has succeeded may be recommended. The timing and method of retesting should be directed by the treating clinician because acid-suppressing medicines and antibiotics can affect test accuracy.
8. Stomach and duodenal ulcers
A peptic ulcer is a defect in the lining of the stomach or duodenum. Common contributors include H. pylori infection and non-steroidal anti-inflammatory medicines. Other causes and aggravating factors may also be relevant.
Gastroscopy documents the ulcer’s location, size, appearance and whether active or recent bleeding is present. Gastric ulcers are commonly biopsied to exclude malignancy and investigate associated gastritis or H. pylori. Duodenal ulcers are very rarely malignant, but sampling and follow-up depend on the clinical context.
Bleeding ulcers can sometimes be treated during gastroscopy using injection, thermal methods, clips or other endoscopic techniques. Severe bleeding may require hospital treatment, blood transfusion, repeat endoscopy, radiological intervention or surgery.
Management can include acid suppression, H. pylori eradication, review of ulcerogenic medicines and follow-up examination where indicated. Patients should not stop medically necessary aspirin, anticoagulants or other medicines without advice, as the risks of interruption must be balanced against bleeding risk.
9. Coeliac disease and duodenal biopsies
Coeliac disease is an immune-mediated condition triggered by gluten in genetically susceptible people. It damages the lining of the small intestine and can impair nutrient absorption.
Gastroscopy allows biopsies to be taken from the duodenum. Microscopic assessment can identify features such as increased inflammatory cells, crypt changes and villous atrophy. Several samples may be collected because changes can be patchy.
The duodenum can appear normal to the endoscopist even when biopsies support coeliac disease. Conversely, visible flattening or scalloping is not sufficient on its own to establish the diagnosis.
Coeliac serology, biopsy results, symptoms and dietary exposure must be interpreted together. Starting a gluten-free diet before testing can allow abnormalities to improve and make diagnosis more difficult. Anyone being investigated should obtain clinical advice before removing gluten.
A confirmed diagnosis generally leads to a strict lifelong gluten-free diet, dietitian support, assessment for nutritional deficiencies and clinical follow-up.
10. Gastric polyps and other lesions
Gastric polyps are growths arising from the stomach lining. They include several pathological types with different causes and implications. Examples include fundic gland polyps, hyperplastic polyps and adenomas.
Some polyps have little malignant potential, while others require removal, surveillance or investigation of the surrounding stomach lining. Size, number, location, appearance and pathology all contribute to management.
Fundic gland polyps can be associated with proton pump inhibitor use or, less commonly, a hereditary polyposis syndrome. Hyperplastic polyps may occur in a background of chronic gastritis. Gastric adenomas are neoplastic lesions with potential to progress and usually require careful management.
A subepithelial lesion is a bulge beneath an otherwise intact mucosal surface. Standard biopsies may not reach the tissue responsible. Endoscopic ultrasound, specialised sampling, imaging, surveillance or removal may be recommended depending on the lesion.
If a mass appears suspicious, biopsies are taken where appropriate. Visual appearance alone does not establish the final diagnosis.
11. Why are biopsies taken?
A biopsy is a small tissue sample obtained using instruments passed through the endoscope. Patients generally do not feel standard mucosal biopsies being taken during the sedated procedure.
Biopsies may be collected to:
- test for H. pylori and characterise gastritis
- investigate coeliac disease
- assess Barrett’s oesophagus or dysplasia
- diagnose eosinophilic oesophagitis
- examine an ulcer, polyp, mass or other lesion
- investigate unexplained inflammation
- monitor a previously diagnosed condition
Biopsies are often taken according to systematic protocols, including from tissue that appears normal. The presence of multiple specimens in a report does not mean that multiple cancers were suspected. Each specimen is labelled by anatomical site so the pathologist and clinician can map findings accurately.
12. Understanding the pathology report
A pathology report commonly includes the specimen site, a macroscopic description, microscopic findings and a diagnostic conclusion. It is written for clinicians and can contain terminology that is easily misunderstood without context.
Terms such as acute inflammation, chronic inflammation, intestinal metaplasia, atrophy and dysplasia describe distinct tissue changes. They are not interchangeable. “Negative for malignancy” means cancer was not identified in the submitted tissue, but another condition may still be present.
The accuracy of interpretation depends partly on sampling. A biopsy represents the tissue removed, not every cell in the organ. The endoscopic appearance, biopsy locations and pathology must therefore be correlated.
Some findings require additional stains, immunohistochemistry, molecular testing or expert review. An amended report may be issued if further information becomes available. Treatment should be based on the final integrated result rather than an isolated preliminary phrase.
Sampling location is especially important in upper gastrointestinal pathology. Inflammation confined to the stomach antrum may have different implications from changes affecting the gastric body, while oesophageal and duodenal specimens answer different diagnostic questions. Reports commonly list specimens in separately labelled containers for this reason. Patients may see several diagnostic entries even though they underwent only one procedure. These entries should be read together with the endoscopy map. A finding described in one site should not be assumed to involve the entire stomach or upper digestive tract, and absence of a change in one specimen does not necessarily determine what is present elsewhere.
13. How long do biopsy results take?
Reporting time varies between pathology providers and according to specimen complexity. Straightforward biopsies may be processed relatively quickly, while unusual or suspicious findings can require additional work.
The hospital or treating practitioner should explain how results will be communicated. Patients should confirm who is responsible for discussing pathology and what to do if the expected communication does not occur.
Where several specimens were submitted, some results may require longer processing than others. A complete follow-up discussion should address the final report rather than only the earliest available component.
No news should not be interpreted as confirmation of a normal result. Administrative delays, incomplete contact details or transfer between practitioners can occur. Retaining a copy of the procedure report and knowing whether tissue was submitted supports appropriate follow-up.
14. What happens after the results?
Next steps depend on the diagnosis. Possible management includes:
- reassurance and follow-up with the referring practitioner
- acid-suppressing treatment
- H. pylori eradication and confirmation testing
- medicine review
- dietitian referral and management of coeliac disease
- surveillance for Barrett’s oesophagus or another condition
- repeat gastroscopy to assess healing or obtain further samples
- advanced endoscopic treatment
- imaging or specialist referral
If cancer is diagnosed, additional testing is ordinarily required to determine the extent and characteristics of the disease. Care may involve upper gastrointestinal surgery, oncology, radiology, pathology and other disciplines. The biopsy result is the beginning of a structured pathway, not the complete prognosis.
Patients should ask what the diagnosis means, whether treatment is required, how response will be assessed, which symptoms require earlier review and whether relatives need any specific advice.
15. Questions to ask about your gastroscopy result
Technical reports are designed primarily for communication between health professionals. A follow-up discussion should translate the findings into a clear diagnosis and management plan. Useful questions include:
- Was the gastroscopy complete, and were all intended areas examined?
- What abnormalities were visible in the oesophagus, stomach or duodenum?
- Were biopsies taken, and from which anatomical sites?
- Was H. pylori identified or excluded using an appropriate test?
- Did the biopsies show inflammation, intestinal metaplasia, atrophy, dysplasia or another cellular change?
- If coeliac disease was being investigated, were adequate duodenal samples obtained and how do they relate to the blood-test results?
- Do I need to begin, stop or change any medicine?
- Is repeat gastroscopy required, and what is the clinical reason for it?
- What symptoms should prompt earlier reassessment?
Patients should mention all acid-suppressing medicines, anti-inflammatory medicines, aspirin, anticoagulants, supplements and recent antibiotics because they may affect the clinical interpretation or management plan. Medicines should not be stopped or changed without advice.
Keeping a copy of the endoscopy and pathology reports can be valuable for future care. The record should include the date, indication, findings, biopsy sites, final diagnosis and any surveillance or treatment recommendation. If responsibility for follow-up is unclear, ask whether the result will be discussed by the endoscopist, GP or another specialist.
16. When should you seek medical advice?
Mild throat discomfort, bloating, wind, nausea and tiredness can occur after gastroscopy. Follow all instructions relating to sedation, driving, supervision, food, fluids and medicines.
Contact the treating hospital or seek urgent assessment for:
- severe or increasing chest or abdominal pain
- breathing or swallowing difficulty
- vomiting blood or material resembling coffee grounds
- black, tarry stools
- significant bleeding
- fever
- persistent vomiting
- fainting, marked weakness or significant deterioration
Serious complications such as perforation, significant bleeding or aspiration are uncommon, but prompt assessment is important when warning signs occur. In a medical emergency, call Triple Zero (000).
17. How Direct Endoscopy can help
Direct Endoscopy provides specialist-led gastroscopy services across Melbourne. Gastroscopy may be recommended to investigate reflux, upper abdominal pain, persistent nausea or vomiting, swallowing difficulty, gastrointestinal bleeding, anaemia, coeliac disease or another upper digestive concern.
Patients can review the comparison of endoscopy, gastroscopy and colonoscopy, access appointment information and find the nearest Direct Endoscopy hospital location.
If gastroscopy and colonoscopy are both being considered, Direct Endoscopy also provides detailed information about colonoscopy services in Melbourne.
18. Final thoughts
A gastroscopy result is often a sequence. The endoscopist records the immediate visual findings and any treatment performed, the pathologist analyses tissue samples, and the treating practitioner integrates those results with symptoms and other investigations.
Biopsy is a routine diagnostic tool and does not by itself imply cancer. Many common findings, including reflux-related inflammation, H. pylori gastritis, ulcers and coeliac disease, are treatable or manageable once accurately characterised.
Confirm how results will be communicated and attend the recommended follow-up. Do not rely on a preliminary explanation when pathology is pending, and seek medical advice if symptoms persist or significant warning signs develop after the procedure.
This article provides general information and does not replace individual medical advice. In a medical emergency, call Triple Zero (000).